1. Chen, Chia-Hsiang, Huang, Yu-Shu, Fang, Ting-Hsuan. 2021. Identification of a novel nonsense homozygous mutation of LINS1 gene in two sisters with intellectual disability, schizophrenia, and anxiety. In Biomedical journal, 44, 748-751. doi:10.1016/j.bj.2021.08.003. https://pubmed.ncbi.nlm.nih.gov/34450347/
2. Li, Xu-Ying, Wang, Zhanjun, Yang, Yanping, Lin, Ruichai, Wang, Chaodong. 2024. Domain-specific phenotypes in LINS1-related disorder-A Chinese family with the Q92X variant and literature review. In American journal of medical genetics. Part C, Seminars in medical genetics, 196, e32085. doi:10.1002/ajmg.c.32085. https://pubmed.ncbi.nlm.nih.gov/38563234/
3. Wen, Pei, Lei, Huiyan, Deng, Hua, Zheng, Yonggang, Pan, Duojia. 2024. Hyd/UBR5 defines a tumor suppressor pathway that links Polycomb repressive complex to regulated protein degradation in tissue growth control and tumorigenesis. In Genes & development, 38, 675-691. doi:10.1101/gad.351856.124. https://pubmed.ncbi.nlm.nih.gov/39137945/
4. Kim, Jin C, Kim, Seon Y, Cho, Dong H, Ju, Hyoungseok, Kim, Yong S. 2011. Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 1200-9. doi:10.1158/1078-0432.CCR-10-1907. https://pubmed.ncbi.nlm.nih.gov/21239504/